The association of 6-minute walk performance and outcomes in stable outpatients with heart failure

Jeptha P Curtis1, Saif S Rathore, Yongfei Wang

  • 1Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520-8088, USA.

Journal of Cardiac Failure
|February 18, 2004
PubMed

Insights

The 6-minute walk test is a valuable tool for predicting mortality risk in heart failure patients. Walking less than 200 meters indicates a significantly higher risk of death, aiding in patient stratification.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Exercise Physiology

Background:

  • The 6-minute walk test (6MWT) is frequently used in clinical practice.
  • Its prognostic value in stable outpatients with heart failure requires further evaluation.

Purpose of the Study:

  • To assess the prognostic significance of the 6-minute walk test distance in stable heart failure outpatients.
  • To determine if 6MWT distance can predict mortality and heart failure-related death.

Main Methods:

  • Analysis of 541 patients from the Digitalis Investigation Group trial.
  • Patients categorized by 6MWT distance: <=200 m, 201-300 m, 301-400 m, and >400 m.
  • Median follow-up of 32 months, assessing all-cause mortality and heart failure-specific death.

Main Results:

  • Patients walking <=200 m had significantly higher all-cause mortality (43.9%) compared to those walking >200 m (23.3%, P<0.001).
  • Mortality rates were similar for patients walking >200 m (23.7% to 19.8%, P for trend 0.45).
  • Distance <=200 m was associated with increased mortality (HR 1.47) and death from worsening heart failure (HR 2.89) in multivariable analysis.

Conclusions:

  • The 6-minute walk test effectively identifies patients walking <=200 m as having a markedly increased risk of death.
  • Standardizing the 6-minute walk test to a time- and distance-based protocol could enhance its efficiency while preserving prognostic information.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...